Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
DMAC | DiaMedica Therapeutics Inc. | Director | $205K | Jan 3, 2023 | ||
TERN | Terns Pharmaceuticals, Inc. | Chief Executive Officer, Director | $137K | +$110K | +423% | Dec 5, 2024 |
TNYA | Tenaya Therapeutics, Inc. | Director | Oct 18, 2024 |
Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
---|